|
Dabigatran Impurity P
|
达比加群杂质 P
|
212322-56-0
|
|
Olmesartan Medoxomil Impurity6
|
奥美沙坦酯杂质6
|
144690-06-2
|
|
Dabigatran Impurity L
|
达比加群杂质 L
|
1580491-16-2
|
|
Linezolid Impurity16
|
利奈唑胺杂质16
|
384344-17-6
|
|
Levocetirizine Impurity 3
|
左西替利嗪杂质3
|
109806-71-5
|
|
Olmesartan Medoxomil Impurity12
|
奥美沙坦酯杂质12
|
172875-59-1
|
|
Gefitinib Impurity 9
|
吉非替尼杂质 9
|
194423-17-1
|
|
Dabigatran etexilate impurity15
|
达比加群酯杂质15
|
211914-51-1
|
|
Olmesartan Medoxomil Impurity3
|
奥美沙坦酯杂质3
|
154709-18-9
|
|
Olmesartan Medoxomil Impurity4
|
奥美沙坦酯杂质4
|
144690-53-9
|
|
LCZ696 impurities4
|
LCZ696杂质4
|
149709-60-4
|
|
Troxagliptin impuritiesT
|
曲格列汀杂质T
|
850649-61-5
|
|
Gefitinib Impurity 4
|
吉非替尼杂质 4
|
861453-16-9
|
|
Clopidogrel Impurities7
|
氯吡格雷杂质7
|
2173294-69-2
|
|
Erlotinib Impurity5
|
厄洛替尼杂质5
|
54060-30-9
|
|
Erlotinib O-Desmethyl Metabolite Isomer (M13)
|
厄洛替尼 O-去甲基代谢物异构体 (M13)
|
183320-29-8
|
|
Clopidogrel Impurities6
|
氯吡格雷杂质6
|
28783-41-7
|
|
Afatinib Impurity13
|
阿法替尼杂质13
|
1194097-41-0
|
|
Dabigatran Impurity K
|
达比加群杂质 K
|
211915-00-3
|
|
Afatinib ImpurityC
|
阿法替尼杂质C
|
945553-91-3
|
|
Afatinib Impurity4
|
阿法替尼杂质4
|
162012-69-3
|
|
Sorafenib impurities12
|
索拉非尼杂质12
|
1285533-84-7
|
|
Gefitinib Impurity 7
|
吉非替尼杂质 7
|
184475-71-6
|
|
alogliptin impurities3
|
阿格列汀杂质3
|
1268836-55-0
|
|
Dabigatran Impurity 17
|
达比加群杂质 17
|
1422495-93-9
|
|
Dabigatran etexilate impurity8
|
达比加群酯杂质8
|
255706-13-9
|
|
Clopidogrel EP Impurity C Sulfate
|
氯吡格雷 EP 杂质 C 硫酸盐
|
120202-71-3
|
|
Clopidogrel Impurities9
|
氯吡格雷杂质9
|
135046-48-9
|
|
Linezolid Impurity1
|
利奈唑胺杂质1
|
1997296-64-6
|
|
Gefitinib Impurity 10
|
吉非替尼杂质 10
|
1006378-06-8
|
|
Linezolid Impurity 23
|
利奈唑胺杂质23
|
216869-17-9
|
|
Olmesartan Medoxomil Impurity16
|
奥美沙坦酯杂质16
|
144690-92-6
|
|
Erlotinib O-Desmethyl Metabolite Isomer (M14)
|
厄洛替尼 O-去甲基代谢物异构体 (M14)
|
183321-86-0
|
|
Olmesartan Medoxomil Impurity18
|
奥美沙坦酯杂质18
|
157356-74-6
|
|
Dabigatran etexilate impurityE
|
达比加群酯杂质E
|
1610758-22-9
|
|
Dabigatran Impurity 24
|
达比加群杂质 24
|
1456889-80-7
|
|
Afatinib Impurity8
|
阿法替尼杂质8
|
314771-76-1
|
|
alogliptin impurities11
|
阿格列汀杂质11
|
1618644-29-3
|
|
LCZ696 impurities518-12
|
LCZ696杂质518-12
|
1639970-62-9
|
|
Sorafenib impurities9
|
索拉非尼杂质9
|
573673-43-5
|
|
Sorafenib impurities1
|
索拉非尼杂质1
|
370-50-3
|
|
Olmesartan Medoxomil Impurity2
|
奥美沙坦酯杂质2
|
761404-85-7
|
|
Gefitinib Impurity 8
|
吉非替尼杂质 8
|
675126-28-0
|
|
Azilsartan medoxomil impurity4
|
阿齐沙坦酯杂质4
|
1442400-68-1
|
|
Erlotinib Impurity3
|
厄洛替尼杂质3
|
183319-69-9
|
|
Cetirizine EP Impurity A
|
西替利嗪 EP 杂质 A
|
303-26-4
|
|
Troxagliptin impuritiesS
|
曲格列汀杂质S
|
1917324-15-2
|
|
Dabigatran etexilate impurity13
|
达比加群酯杂质13
|
1408238-40-3
|
|
Olmesartan Medoxomil Impurity15
|
奥美沙坦酯杂质15
|
1227626-51-8
|
|
Afatinib Impurity12
|
阿法替尼杂质12
|
162012-70-6
|
|
Dabigatran etexilate impurity12
|
达比加群酯杂质12
|
1422435-41-3
|
|
Olmesartan Medoxomil Impurity17
|
奥美沙坦酯杂质17
|
2101308-74-9
|
|
alogliptin impurities5
|
阿格列汀杂质5
|
1820685-30-0
|
|
Olmesartan Medoxomil EP Impurity D
|
奥美沙坦酯 EP 杂质 D
|
1020157-01-0
|
|
Sorafenib impurities8
|
索拉非尼杂质8
|
284461-74-1
|
|
Azilsartan medoxomil Impurity D
|
阿齐沙坦酯杂质D
|
1821386-21-3
|
|
Linezolid Impurity 22
|
利奈唑胺杂质22
|
1610690-08-8
|
|
Clopidogrel EP Impurity B
|
氯吡格雷EP杂质B
|
1396841-05-6
|
|
Linezolid Impurity12
|
利奈唑胺杂质12
|
2307625-63-2
|
|
N,O-Desethylene Linezolid
|
N,O-去乙烯利奈唑胺
|
1219708-30-1
|
|
Sorafenib impurities11
|
索拉非尼杂质11
|
583840-03-3
|
|
Levocetirizine Impurity 2
|
左西替利嗪杂质2
|
1150310-68-1
|
|
Troxagliptin impurities2
|
曲格列汀杂质2
|
1812193-01-3
|
|
Linezolid Impurity5
|
利奈唑胺杂质5
|
556801-09-3
|
|
Troxagliptin impuritiesI
|
曲格列汀杂质I
|
1917324-13-0
|
|
Dechlorocetirizine dihydrochloride
|
脱氯西替利嗪二盐酸盐
|
83881-54-3
|
|
Afatinib ImpurityD
|
阿法替尼杂质D
|
1680184-59-1
|
|
Troxagliptin impurities5
|
曲格列汀杂质5
|
2087874-92-6
|
|
Cetirizine USP Impurity B
|
西替利嗪USP杂质B
|
108983-83-1
|
|
Linezolid Impurity17
|
利奈唑胺杂质17
|
333753-71-2
|
|
Linezolid Impurity 19
|
利奈唑胺杂质19
|
1532560-87-4
|
|
alogliptin impurities10
|
阿格列汀杂质10
|
865758-95-8
|
|
Linezolid Impurity 18
|
利奈唑胺杂质18
|
174649-09-3
|
|
Sorafenib impurities2
|
索拉非尼杂质2
|
1431697-81-2
|
|
Clopidogrel EP Impurity F HCl
|
氯吡格雷 EP 杂质 F HCl
|
141109-19-5
|
|
Oxcarbazepine EP Impurity K
|
奥卡西平 EP 杂质 K
|
1346601-76-0
|
|
Linezolid Impurity10
|
利奈唑胺杂质10
|
168828-81-7
|
|
Dabigatran Etexilate N-Oxide
|
达比加群酯 N-氧化物
|
1381757-44-3
|
|
Azilsartan medoxomil Impurity M
|
阿齐沙坦酯杂质M
|
632322-61-3
|
|
alogliptin impurities14
|
阿格列汀杂质14
|
309956-78-3
|
|
Sorafenib impurities12
|
索拉非尼杂质12
|
2204442-52-2
|
|
Clopidogrel EP Impurity E(R)
|
氯吡格雷 EP 杂质 E(R)
|
444728-15-8
|
|
Olmesartan Medoxomil Impurity1
|
奥美沙坦酯杂质1
|
144689-23-6
|
|
Troxagliptin impurities3
|
曲格列汀杂质3
|
1821400-07-0
|
|
Dabigatran etexilate impurity5
|
达比加群酯杂质5
|
872728-85-3
|
|
Dabigatran Impurity 20
|
达比加群杂质 20
|
1422435-40-2
|
|
alogliptin impurities12
|
阿格列汀杂质12
|
2276323-24-9
|
|
Sorafenib impurities13
|
索拉非尼杂质13
|
220000-87-3
|
|
Cetirizine EP Impurity E
|
西替利嗪 EP 杂质 E
|
682323-77-9
|
|
Olmesartan Medoxomil Impurity9
|
奥美沙坦酯杂质9
|
51802-42-7
|
|
Linezolid Impurity9
|
利奈唑胺杂质9
|
348626-43-7
|
|
Levocetirizine Impurity 4
|
左西替利嗪杂质4
|
58023-19-1
|
|
Oxcarbazepine EP Impurity G
|
奥卡西平 EP 杂质 G
|
1219170-51-0
|
|
Dabigatran etexilate impurity7
|
达比加群酯杂质7
|
1642853-67-5
|
|
Sorafenib impurities3
|
索拉非尼杂质3
|
2004659-83-8
|
|
Gefitinib Impurity 1
|
吉非替尼杂质 1
|
230955-75-6
|
|
Azilsartan medoxomil Impurity A
|
阿齐沙坦杂质A
|
147404-76-0
|
|
Azilsartan medoxomil Impurity O
|
阿齐沙坦杂质O
|
1675221-59-6
|
|
LCZ696 impuritiesF
|
LCZ696杂质F
|
1012341-54-6
|
|
Azilsartan medoxomil impurity2
|
阿齐沙坦酯杂质2
|
1442400-65-8
|